Jump to Main Content

ASH Annual Meeting and Exposition

Special Interest Sessions

Special Interest sessions provide the opportunity for ASH’s various communities to focus on specific topics of interest, ranging from coping with physician stress and burnout, to counseling fellows on careers in hematology, to the impact of ASH’s international outreach programs.

Unless otherwise noted, all sessions will take place in person and stream simultaneously on the virtual platform. Session recordings will be available on demand on the virtual platform.

Artificial Intelligence in Hematology: From Generative AI to Ethics and Applications

The session will address important and timely topics related to the application of artificial intelligence (AI) to hematology, ranging from generative AI's potential and pitfalls, modern ethical consideration for AI in biomedical research and examples of practical use of AI in hematology research and clinical care.

Chair:

Olivier Elemento, PhD
Weill Cornell Medicine
New York, NY

Speakers:

James Zou, PhD
Stanford University
Stanford, CA
The Potential and Pitfalls of Generative AI in Basic and Clinical Research

Camille Nebeker, PhD
University of California San Diego
San Diego, CA
From Principles to Practice: Ensuring Ethical Integrity in AI-Driven Biomedical Research

Claudia Haferlach, MD
MLL Munich Leukemia Laboratory
Munich, Germany
The Application of Artificial Intelligence in Hematological Diagnostics

back to top

ASH Clinical Practice Guidelines on Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults

This session will preview recommendations for initial therapy and management of remission and relapse in adolescents and young adults with ALL.

Chair:

Sumit Gupta, MD, PhD
Hospital for Sick Children
Toronto, ON, Canada

Speakers:

Julie Wolfson, MD, MSHS
The University of Alabama at Birmingham
Birmingham, AL
Initial Therapy for ALL in Adolescents and Young Adults

Jennifer L. McNeer, MD
University of Chicago
Chicago, IL
Initial Therapy for ALL in Adolescents and Young Adults

Kristen M. O'Dwyer, MD
University of Rochester Medical Center
Rochester, NY
Management of Remission and Relapse of ALL in Adolescents and Young Adults

Lena E Winestone, MD
University of California San Francisco
San Francisco, CA
Management of Remission and Relapse of ALL in Adolescents and Young Adults

back to top

ASH Clinical Practice Guidelines on Amyloidosis

This session will review the scope and goals of the upcoming guidelines on amyloidosis, and will provide insights on risk factors, selecting a target site versus a surrogate site for diagnostic biopsies, and using Congo Red stain screening.

Chair:

Vishal Kukreti
University Health Network
Toronto, ON, Canada

Speakers:

Angela Dispenzieri, MD
Mayo Clinic
Rochester, MN
Target Site vs. Surrogate Site Biopsy for Diagnosis

Joselle Cook, MBBS
Mayo
Rochester, MN
Increasing Awareness of Risk Factors for AL Amyloidosis

Naresh Bumma, MD
The Ohio State University
COLUMBUS, OH
Congo Red Stain Screening for AL Amyloidosis

back to top

ASH Clinical Practice Guidelines on Pediatric Venous Thromboembolism (VTE)

This session will highlight new and revised recommendations for the treatment of VTE in pediatric patients, including addressing asymptomatic VTE, duration of therapy for provoked and unprovoked VTE, and use of anticoagulants.

Chair:

Paul Monagle
University of Melbourne Royal Children's Hospital
Parkville, VIC, Australia

Speakers:

Leslie Raffini, MD
Children's Hospital of Philadelphia
Philadelphia, PA
Why Revise the Guidelines?

Rukhmi Bhat, MD,MS
Lurie Children's Hospital
Chicago, IL
Asymptomatic VTE in Pediatric Patients

Marisol Betensky, MD
Johns Hopkins All Children's Hospital
Saint Petersburg, FL
Duration of Therapy for Provoked and Unprovoked VTE in Pediatric Patients

Tina Biss
The Newcastle upon Tyne Hospitals NHS Trust
Newcastle Upon Tyne, ENG, United Kingdom
Use of Anticoagulants in Children

back to top

ASH Clinicians in Practice (ACIP) Lunch - The Role of Artificial Intelligence in Hematology Practice: The Good, the Bad, and the Ugly

Artificial Intelligence (AI) has the potential to transform health care by enhancing diagnostic accuracy, predicting patient outcomes, and developing personalized treatment plans. Machine learning algorithms can analyze vast amounts of medical data, leading to more efficient and precise health care interventions, which could improve patient care and reduce costs. However, implementation of AI in health care also poses challenges related to data privacy concerns, ethical considerations, and the need for robust regulatory frameworks to ensure the responsible and secure use of sensitive medical information. In this session, panelists will speak on the recent advances and use of AI in health care, how it’s integrated into hematology practice by providers, and the use of AI by patients.

Chair:

Mary-Elizabeth M. Percival, MD
Seattle Cancer Care Alliance
Seattle, WA

Speakers:

Jim Whitfill
Honor Health
Phoenix, AZ
Artificial Intelligence in Health Care: Benefits and Pitfalls

Christopher Manz
DFCI
Boston, MA
Artificial Intelligence as a Clinical Tool: Hacks in Practice

Gwen Nichols, MD
The Leukemia and Lymphoma Society
Rye Brook, NY
Patient Facing Artificial Intelligence: Uses and Ethical Implications

back to top

ASH Quality Improvement Champions

This new session merges the ASH Choosing Wisely Champions and the ASH Guideline Implementation Champions into a single, 90-minute session. Speakers will be selected from a pool of applicants. In addition to projects that combat overuse (previously the focus of the Choosing Wisely Champions session) and projects that highlight successful guideline implementation strategies (previously the focus of the Guideline Implementation Champions session), the call for applications for this session considers any quality improvement project (e.g., combating underuse, improving stewardship of resources, improving processes, reducing or eliminating healthcare disparities, etc.). The goal of this change is to expand opportunities to highlight high-quality quality improvement work while concentrating the focus into a single session.

Co-Chairs:

Ming Y. Lim, MBBChir
University of Utah Health
Salt Lake Cty, UT

Rachel P. Rosovsky, MD
Massachusetts General Hospital
Boston, MA

Speakers:

Paolo Lopedote, MD
St Elizabeth's Medical Center
Boston, MA
Reducing Blood Products Administration in Cirrhotic Patients Undergoing Paracentesis

Asinamai M Ndai, MS,BPharm
University of Florida Health Physicians
Gainesville, FL
Rapid Recognition and Optimal Management of Hemophilia in the Emergency Department: A Quality Improvement Project

Josaura Fernandez Sanchez, MD
Texas Children’s Cancer and Hematology Centers
Houston, TX
Improving and Standardizing the Evaluation and Management of Iron Deficiency Anemia Secondary to Heavy Menstrual Bleeding in the Emergency Department

back to top

ASH Research Collaborative Data Hub Sickle Cell Disease Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation

Session Description: During this 90-minute special-interest session, sickle cell disease (SCD) registry and real-world evidence (RWE) leaders will discuss progress across numerous SCD data initiatives, including the ASH Research Collaborative’s SCD Data Hub and other federal and non-federal programs. Specific topics include examples of using real-world data (RWD) to generate RWE, how RWD can be used to monitor clinical practice and outcomes for patients who receive cell and gene therapies, various approaches to ensuring data quality when using electronic health record data (EHR), federal priorities related to RWE generation that supports regulated research, and a new project to increased SCD-specific data standards within EHRs.   

Co-Chairs:

Alexis A. Thompson, MD, MPH
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA

Ted Wun, MD
Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center
Sacramento, CA

Speakers:

Alexis A. Thompson, MD, MPH
Children's Hospital of Philadelphia
Philadelphia, PA
Representing Sickle Cell Disease Health Concepts in Real World Evidence Generation: examples from real world data (RWD) initiatives and the importance to the sickle cell disease community

Patty Steinert
Medical College of Wisconsin
Milwaukee, WI
The Role of RWD in Long-Term Follow-up of Cell and Gene Therapies in Sickle Cell Disease: The CIBMTR experience

Sophie Lanzkron
Thomas Jefferson University
Baltimore, MD
Challenges in Data Quality: Where EHR Data Acquisition Approaches and Highly-Curated Datasets Intersect (1)

Ashima Singh, PhD
Medical College of Wisconsin
Pewaukee, WI
Challenges in Data Quality: Where EHR Data Acquisition Approaches and Highly-Curated Datasets Intersect (2)

Nicole Verdun
FDA
Silver Spring, MD
Regulatory Perspective: Why RWD is Critical for Evaluation of SCD Disease Modifying Curative Therapies

Laverne Perlie, MSN
Health and Human Services
Washington, DC
Bringing It All Together: How the Federal Government Is Facilitating Collaboration across the Sickle Cell Data Landscape

back to top

ASH Research Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation

This 90-minute special-interest session will focus on the ASH Research Collaborative’s Multiple Myeloma Program’s efforts to accelerate research and collaborative clinical care in hematologic malignancies. Three topics will describe the ASH Research Collaborative’s approach to aggregating and visualizing real-world data (RWD) in multiple myeloma in a US-based, multi-site network; a proof-of-concept study with a hybrid decentralized workflow that was conducted in the ASH RC Myeloma Network this year; and new directions for RWD analysis in hematologic malignancies, including the use of artificial intelligence. A panel will then highlight work that is being done by the European HARMONY Alliance and other real world data registries.

Chair:

William A Wood, MD, MPH
University of North Carolina At Chapel Hill Hospital
Chapel Hill, NC

Speakers:

Kenneth C. Anderson, MD
Dana-farber/Boston Children's Cancer and Blood Disorders Ctr
Boston, MA
Building a National Multiple Myeloma Data Hub to Accelerate Research and Enhance Clinical Care

Saad Z Usmani, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Working with Data Hub Data and Network PIs to Develop Evidence that Changes Practice in Multiple Myeloma: The COSMIC Study as Proof of Concept

Shaji Kunnathu Kumar, MD
Mayo Clinic
Rochester, MN
Pushing Data Frontiers: How Artificial Intelligence and Molecular Data can Facilitate Translational Research in the Network

Jesús María Hernández-Rivas, PhD
University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Department of Hematology - Hospital Universitario de Salamanca
Salamanca, Spain
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 1)

Elena Zamagni, MD, PhD
Bologna University School of Medicine
Bologna, Italy
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 2)

Doris K. Hansen, MD
Moffitt Cancer Center
Tampa, FL
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 3)

back to top

Blood Advances Presents: How to Peer Review a Scientific Paper

Peer review plays a vital role in the dissemination and assessment of scientific research. Authors benefit from receiving an independent assessment of their work and reviewers benefit by gaining access to novel data. Dr. Catherine Bollard and Dr. Andrew Weyrich, the editor-in-chief and deputy editor for Blood Advances, will present recommended practices for reviewing a scientific paper for a peer-reviewed journal. The session will include topics such as things to consider when accepting or declining an invitation to review, how to write a review that is helpful for authors and editors, and what a reviewer should do if they suspect a possible research integrity issue. The presentation will be followed by a period for audience questions.

Panelists:

Catherine M. Bollard, MD
Children's National Hospital and The George Washington University
Washington, DC

Andrew S. Weyrich, PhD
Oklahoma Medical Research Foundation
Oklahoma City, OK

back to top

Blood Presents: How to Get Published in a Peer-Reviewed Journal

Peer-reviewed journals serve a crucial role in helping researchers refine and publicize their work and helping readers sort through the ever-expanding scientific literature. Yet finding the right journal for one's research and framing data properly can be a challenge. Dr. Nancy Berliner and Dr. Andrew Roberts, the editor-in-chief and deputy editor for Blood, will present recommended practices for writing a scientific paper and submitting it to a peer-reviewed journal. The session will include topics such as how to develop the "story" for your research, how to respond to reviewer comments, and what to do when your submission is rejected. The presentation will be followed by a period for audience questions.

Panelists:

Nancy Berliner, MD
Brigham and Women's Hospital
Boston, MA

Andrew W. Roberts, MBBS, PhD
The Walter and Eliza Hall Institute of Medical Research
Parkville, VIC, Australia

back to top

Early Faculty Career Development Session

In this Junior Faculty Career Development Session, attendees will hear a series of lectures focused on Mentorship. These didactic lectures will feature mentoring experts sharing their experiences in how to receive, provide, and optimize mentoring. Mentor/Mentee relationships can be hard to foster, and in this session, we will focus on empowering junior faculty with the tools to get the most out of this relationship. Junior faculty will hear from mentors and mentees both in the clinical and basic research fields and gain a better understanding on what it is to be a good mentor and mentee.

Co-Chairs:

Adam Scott Kittai, MD
The Ohio State University
Columbus, OH

Andrew G Volk
Cincinnati Children's Hospital Medical Center
Cincinnati, OH

Speakers:

Betty Pace
Augusta University
Augusta, GA
Identifying a Mentor and Optimizing the Mentor/Mentee Relationship, How to be a Good Mentee?

Adam Scott Kittai, MD
The Ohio State University
Columbus, OH
Identifying a Mentor and Optimizing the Mentor/Mentee Relationship, How to be a Good Mentee?

Joseph Mikhael
Translational Genomics Research Institute
Phoenix, AZ
The Warning Signs of a Problematic Mentoring Relationship and How to Fix it

Shannon Elf, PhD
The University of Chicago
Chicago, IL
The Warning Signs of a Problematic Mentoring Relationship and How to Fix it

Leidy Isenalumhe
Moffitt Cancer Center
Lutz, FL
Transitioning from Being a Mentee to Becoming a Mentor

Raquel Espin Palazon, PhD
Iowa State University
Ames, IA
Transitioning from Being a Mentee to Becoming a Mentor

back to top

Grassroots Network Lunch

The ASH Grassroots Network Lunch provides a forum for interested members to learn how they can participate in ASH’s advocacy efforts, communicate with Congress and their elected officials, become effective advocates for hematology, and discuss the Society’s legislative and regulatory priorities. An overview of the Society’s 2024 advocacy accomplishments and a preview of the Society’s 2025 advocacy agenda will also be provided.

Co-Chairs:

Jennifer Holter-Chakrabarty, MD
University of Oklahoma Stephenson Cancer Center
Oklahoma City, OK

Bart L. Scott, MD
Fred Hutchinson Cancer Center
Seattle, WA

Speaker:

Kirk Bado
National Journal
Washington, DC
Grassroots Network Lunch

back to top

Health Equity Rounds Lunch

Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.

Co-Chairs:

Yvonne Adeduni Efebera, MD, MPH
Ohio Health
Columbus, OH

Srinivas Devarakonda, MD
The Ohio State University
Columbus, OH

Speakers:

Ash Alpert
Yale School of Medicine
New Haven, CT
Hematologic Aspects of Gender Affirming Care

Eric Scott Mullins, MD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH
Hematologic Aspects of Gender Affirming Care

back to top

Health Equity Symposium: Race, Structural Racism and the Social Determinants of Health in Hematology

The misuse of race in medicine has far-reaching implications across practice, teaching, and research in hematology. This session is intended to explore what race is and what it is not, and illustrate how systemic factors, including racism, influence health care access and outcomes. The session will also explore strategies to tackle systemic racism in patient care and how to create conditions for equitable care for patients with blood diseases. Dr. Joseph L. Graves Jr. will provide a summary of the history of biological conceptions of race and describe modern evolutionary conceptions of race. He will then address how this understanding can be useful in employing the power of modern genomic tools applied to human biological diversity, including how the use of these tools completely unravels the false premises of racial medicine. Dr. Chanita Hughes Halbert will define health care disparities and describe the nature and distribution of social determinants of disparities in disease risk and outcomes. She will also provide an overview of structural racism and its impact on health care outcomes in diverse populations.

Chair:

Deirdra R Terrell, PhD
University of Oklahoma Health Sciences Center
Oklahoma City, OK

Speakers:

Joseph L Graves Jr., PhD
North Carolina A&T State University
Greensboro, NC
The Myth of Race in Medical Science

Chanita Hughes Halbert, PhD
University of Southern California
Los Angeles, CA
Structural Racism, the Social Determinants of Health, and Healthcare Outcomes – Understanding Inequity and What to Do About It

back to top

LGBTQIA+ Community Networking Lunch (for in-person participants)

This is an informal community-building and networking event for members of the LGBTQIA+ community attending the meeting. The event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create a sense of belonging and allyship and, where possible, identify opportunities to learn more about the experiences and needs of the community to allow us to have a greater impact in our DEI efforts.

back to top

Medical Educators Symposium

The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with an hour of general sessions focused on medical education principles and then followed by simultaneous breakout sessions that happen twice.

Chair:

Hetty E. Carraway, MD,MBA
Cleveland Clinic
Cleveland, OH

Speakers:

Alison Loren, MD
University of Pennsylvania
Philadelphia, PA
General Session 1: Paving a Career in Medical Education & Scholarship

Megan Dupuis
Vanderbilt University
Durham, NC
General Session 2: Utilizing Humanities to Influence and Tailor Hematology Curriculum for Adult Learners

Layla Van Doren
Yale University
New York, NY
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum

Alexander A Boucher, MD
University of Minnesota
Minneapolis, MN
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum

Beverly Schaefer, MD
University of Buffalo
Buffalo, NY
Breakout 1: Challenges for Course Development

Ariela Marshall
University of Minnesota
Rochester, MN
Breakout 2: Developing Your Teaching Portfolio

Jason A Freed, MD
Beth Israel Deaconess
Boston, MA
Breakout 3: Cutting-Edge Technology in Education Delivery

Thomas W. LeBlanc, MD, MA, MHS
Duke University Medical Center
Durham, NC
Breakout 4: Developing a Palliative Care/Difficult Discussion Curriculum

Panelist:

Ariela Marshall
University of Minnesota
Rochester, MN

back to top

Race and Ancestry in Precision Medicine

Race and ancestry, historically, have been poorly considered in basic and translational research design and clinical diagnoses. This session will describe how race and ancestry can inform hematology research conduct, specifically in clinical and genetic population profiling, interpretation of common hematologic tests, development of diagnostics, and overall precision medicine. The speakers selected in this session have incorporated race and ancestry in their own research and will be sharing their insights to help educate hematology investigators and clinicians understand how to consider race and ancestry into their own research and practice.

Co-Chairs:

Jennifer J. Trowbridge, PhD
The Jackson Laboratory
Bar Harbor, ME

Sant-Rayn Pasricha, MD,PhD
Walter and Eliza Hall Institute of Medical Research
Fitzroy North, VIC, Australia

Speakers:

Keolu Fox
University of California, San Diego
San Diego, CA
Incorporating Indigenous Perspectives into Population Genetics

Ann-Kathrin Eisfeld, MD
The Ohio State University
Columbus, OH
Risk Re-Stratification Based on Black AML Patient Exome Data

Maureen Achebe
Brigham and Women's Hospital
Boston, MA
How Inappropriate Reference Ranges Can Propagate Systemic Racism

back to top

Symposium for Mid-Career Hematologists

Special Symposium for Mid-Career Hematologists

This symposium aims to guide the audience through the common challenges faced by mid-career hematologists. Some examples of unique challenges for mid-career hematologists include negotiating the first leadership position, principles of leadership, promotion, strategies for managing individuals and teams, conflict management, setting up a successful research program, time management, funding beyond career development awards, performance and compensation metrics, self-care and opportunities to contribute to the Society’s mission. Speakers will include a diverse pool of successful physicians and scientists from academia, regulatory agencies, and the pharmaceutical industry. It is envisioned that this educational session will be organized by a steering committee of Society members who will identify a longitudinal curriculum for the session and speakers and topics.

Chairs:

Juan Pablo Alderuccio, MD
Sylvester Comprehensive Cancer Center University of Miami
Miami, FL

Shruti Chaturvedi, MBBS
Johns Hopkins University
Baltimore, MD

Speakers:

Ruben A. Mesa, MD
Atrium Health Wake Forest Baptist
Winston-Salem, NC
Negotiating Your First Leadership Position

Allison A King, MD, MPH, PhD
Washington University School of Medicine in St. Louis
Saint Louis, MO
Negotiating Your First Leadership Position

Robert F. Sidonio, Jr., MD,MSc
Emory University
Atlanta, GA
Your Next Job - How to Identify Academic Opportunities with the Best Payback

Jeffrey Lebensburger, DO
University of Alabama at Birmingham
Birmingham, AL
Your Next Job - How to Identify Academic Opportunities with the Best Payback

Nina Shah, MD
AstraZeneca
South San Francisco, CA
Making the Jump - Careers Outside Academia

David P. Steensma, MD
Ajax Therapeutics
Lincoln, MA
Making the Jump - Careers Outside Academia

back to top

Symposium on Quality: Treating Fairly - The Role of Quality Improvement in Combating Health Care Disparities

This year's Quality Symposium will focus on practical strategies for combatting healthcare disparities. First, Dr. Melissa Creary will discuss the Michigan Social Health Interventions to Eliminate Disparities (MSHIELD) program, a statewide data-driven, community-partnered, and equity-centered quality improvement effort. Then Dr. Michelle Sholzberg will review the development and impact of the "Raise the Bar" project, which aims to eliminate disparities in the recognition and management of iron deficiency by adjusting reference ranges. The session will conclude with a talk by Dr. Thomas Greg Knight on mitigating the impact of financial toxicity in patients with hematologic malignancies.

Co-Chairs:

Angela C Weyand, MD
University of Michigan
Ann Arbor, MI

Adam Cuker, MD, MS
University of Pennsylvania
Philadelphia, PA

Speakers:

Melissa Creary
University of Michigan School of Public Health
Ann Arbor, MI
MSHIELD - Michigan Social Health Interventions to Eliminate Disparities

Michelle Sholzberg, MD
University of Toronto
Toronto, ON, Canada
Raise the Bar - Combatting Disparities in the Recognition and Management of Iron Deficiency

Thomas G. Knight, MD
Atrium Health
Charlotte, NC
Cancer and Poverty - Mitigating the Impact of Financial Toxicity in Patients with Hematologic Malignancies

back to top

Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management

This session will feature two talks on systems-level approaches to anticoagulation management, followed by a networking session where attendees will meet with the speakers and with established systems-based hematologists over light hors d'oeuvres and drinks. The first talk with feature Dr. Greg Barnes discussing how to improve systems-level management of anticoagulants within and across care settings. For the second talk, Dr. Damon E. Houghton will discuss the use of artificial intelligence (AI) and machine learning (ML) in the context of anticoagulation management.

Chair:

Camila Masias, MD,MPH
Miami Cancer Institute
Miami, FL

Speakers:

Geoffrey Barnes, MD, MSc
University of Michigan
Ann Arbor, MI
Improving Systems-Level Management of Anticoagulants Within and Across Care Settings

Damon E. Houghton, MD,MS
Mayo Clinic Rochester
Rochester, MN
Artificial Intelligence (AI) and Machine Learning (ML) in the Context of Anticoagulation Management

back to top

Training Program Directors Workshop

The Training Program Director’s Workshop is held each year before the ASH annual meeting and is designed for training program directors, associate program directors, and others involved with hematology training. The workshop is designed for hematology program directors to share lessons learned, best practice, and explore opportunities to improve their leadership skills. Through experiential learning techniques, breakout sessions, and interactive lectures, program directors can learn from peers and build their network. At this year’s TPDW, we will focus on three opportune topics. First, we will discuss how to design and implement innovative curriculums which can prepare trainees to excel at various aspects of hematology oncology practice beyond just knowledge of the subject matter. Examples of such curriculums include ‘leadership training’, ‘how to be a good educator’, and ‘business of hematology-oncology’. Second, we will focus on best practices for a training program to leverage social media and build their ‘brand’. Lastly, we will discuss practical ways in which programs can help trainees land their dream job.

Chair:

Pallawi Torka
Roswell Park Cancer Center
Buffalo, NY

Speakers:

Scott Moerdler, MD
Rutgers Cancer Institute
New Brunswick, NJ
Innovative Fellowship Curriculum

Layla N Van Doren, MD, MBA
Yale University
New Haven, CT
Innovative Fellowship Curriculum

Angela C Weyand, MD
University of Michigan
Ann Arbor, MI
Leveraging and Enriching Social Media

Gerald Hsu, MD,PhD
University of California, San Francisco
San Francisco, CA
Best Practices to Support Fellows in the Job Search

Sunandana Chandra
Northwestern University
Chicago, IL
Best Practices to Support Fellows in the Job Search

back to top

Wake Up to DEI Community Networking Brunch (for in-person participants)

This is a community-building and networking event for members that fall within the diversity, equity, and inclusion (DEI) umbrella to gather and get to know each other across the varying and intersectional communities. The event will include remarks from a member of the ASH Committee on Diversity, Equity, and Inclusion.

The event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create space for ASH DEI communities and allies and, where possible, identify opportunities to learn more about the experiences and needs of these communities to allow ASH to have a greater impact in its DEI efforts.

back to top

Women In Hematology Networking Event (for in-person participants)

This popular annual reception will provide a space where all can gather in an informal environment and connect with peers and potential mentors. The event will include a panel discussion focused on leadership through a gender and career development lens as well as ample networking opportunities.

Moderators:

Bethany Samuelson Bannow, MD
Oregon Health and Science University
Portland, OR

Glaivy Batsuli, MD
Stanford University
Stanford, CA